Medical Journals

Phosphatidylinositol 4-phosphatase Type Ii is an Erythropoietin-responsive Gene.

Authors:
  • Barnache S
  • Le Scolan E
  • Kosmider O
  • Denis N
  • Moreau-Gachelin F

From: Inserm U528, Institut Curie, Paris, France.

Oncogene

  • Publish Date: Mar 2006
  • ISSN: 0950-9232
  • Volume: 25
  • Issue: 9
  • Pages: 1420-3
  • Medium: Print
  • Language: English
  • Citation (JAMA): Barnache S, Le Scolan E, Kosmider O, et al. Phosphatidylinositol 4-phosphatase Type Ii is an Erythropoietin-responsive Gene.. Oncogene Mar 2006;25:1420-3

Abstract

The erythroleukemia developed by spi-1/PU.1 transgenic mice is a multistep process. At disease onset, preleukemic cells are arrested in differentiation at the proerythroblast stage (HS1 stage) and their survival and growth are under the tight control of erythropoietin (Epo). During disease progression, malignant proerythroblasts characterized by Epo autonomous growth and in vivo tumorigenicity can be isolated (HS2 stage). During analysis of transcriptional profiling representive of discrete stages of leukemic progression, we found that the phosphatidylinositol 4-phosphatase type II gene was turned off in malignant cells. PI-4-phosphatase II is an enzyme that hydrolyses the 4-phosphate position of phosphatidylinositol-3-4-bisphosphate (PtdIns(3,4)P(2)) to form PtdIns(3)P. Using malignant cells engineered to stably express PI-4-phosphatase II, we showed that PI-4-phosphatase II reduced Akt activation level. Moreover, stimulation of malignant cells with Epo-induced PI-4-phosphatase II transcription pointing this gene as an Epo-responsive gene. This study provides first insight for a physiological role of PI-4-phosphatase II in the proerythroblast by controlling Epo responsiveness through a negative regulation of the PI3K/Akt pathway.

Mesh Headings (Keywords): 1-Phosphatidylinositol 3-Kinase, Animals, Blotting, Northern, Cell Differentiation, Cell Survival, Cell Transformation, Neoplastic, Erythroblasts, Erythropoietin, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Leukemia, Erythroblastic, Acute, Mice, Mice, Transgenic, Oncogene Protein v-akt, Phosphoric Monoester Hydrolases, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Transcription, Genetic, Tumor Cells, Cultured


Check for Full Text / PubMed Unique Identifier (PMID): 16247441


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.